New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 2, 2014
16:07 EDTACT, IPXLImpax acquires two generic products from Actavis
Impax (IPXL) has acquired from Actavis (ACT) two generic products for cash consideration. Financial terms of the agreement were not disclosed. The acquisition includes one product marketed under an Abbreviated New Drug Application - Ursodiol tablet - and one approved ANDA that is not yet marketed - Lamotrigine orally disintegrating tablet.
News For IPXL;ACT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for IPXL;ACT

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use